Stock Events

Stock Events

Elanco Animal Health 

€20.97
60
+€0.04+0.19% Monday 08:31

Statistics

Day High
21.01
Day Low
20.91
52W High
24.04
52W Low
15.47
Volume
-
Avg. Volume
-
Mkt Cap
10.48B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

10NovExpected
Q1 2026
Q2 2026
Next
0.18
0.23
0.29
0.34
Expected EPS
0.17711391776
Actual EPS
N/A

Financials

-4.71%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
4.1BRevenue
-192.94MNet Income

Analyst Ratings

23.07Average Price Target
The highest estimate is 25.04.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy
80%
Hold
20%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 5EA.STU. It's not an investment recommendation.
Microsoft
20
MSFT
Amazon
20
AMZN
Tesla
19
TSLA
Alphabet
19
GOOGL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zoetis
ZTS
Mkt Cap31.33B
Zoetis is a global leader in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines, directly competing with Elanco in both the companion and livestock animal product markets.
Merck
MRK
Mkt Cap370.89B
Merck & Co., through its animal health division, offers veterinary pharmaceuticals, vaccines, and health management solutions and services, making it a direct competitor to Elanco in multiple segments of the animal health industry.
Phibro Animal Health
PAHC
Mkt Cap1.55B
Phibro Animal Health Corporation operates in the animal health and mineral nutrition markets, offering medicated feed additives, which puts it in direct competition with Elanco's product offerings.
Idexx Laboratories
IDXX
Mkt Cap42.18B
IDEXX Laboratories, Inc. provides diagnostic, detection, and information systems for veterinary, livestock, and poultry services, competing with Elanco in the animal health diagnostics market.
Abbott Laboratories
ABT
Mkt Cap187.45B
Abbott Laboratories, through its animal health division (before divestiture), offered products that competed with Elanco in diagnostics and nutrition, although its focus has shifted, it remains a competitor through legacy products and technologies.
Pfizer
PFE
Mkt Cap162.16B
Pfizer, prior to the spin-off of its animal health division into Zoetis, was a direct competitor in the development and commercialization of animal health products, and it maintains a presence in the market through ongoing investments and partnerships.
Elia Group SA/NV
ELI.BR
Mkt Cap14.92B
Elia System Operator provides infrastructure and services for the energy sector but is included erroneously as it does not compete in the animal health sector, illustrating the importance of accurate industry classification.

About

Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.
Show more...
CEO
Jeffrey N. Simmons
Employees
9900
Country
United States
ISIN
US28414H1032
WKN
000A2N6BH

Listings

STU
DE
5EA.STU
MU
DE
5EA.MU
F
DE
5EA.F
XNYS
US
ELAN

0 Comments

Share your thoughts

FAQ

What is Elanco Animal Health stock price today?▼
The current price of 5EA.STU is €20.97 EUR — it has increased by +0.19% in the past 24 hours. Watch Elanco Animal Health stock price performance more closely on the chart.
What is Elanco Animal Health stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Elanco Animal Health stocks are traded under the ticker 5EA.STU.
Is Elanco Animal Health stock price growing?▼
5EA.STU stock has risen by +0.96% compared to the previous week, the month change is a +9.19% rise, over the last year Elanco Animal Health has showed a +31.51% increase.
What is Elanco Animal Health market cap?▼
Today Elanco Animal Health has the market capitalization of 10.48B
When is the next Elanco Animal Health earnings date?▼
Elanco Animal Health is going to release the next earnings report on November 10, 2026.
What were Elanco Animal Health earnings last quarter?▼
5EA.STU earnings for the last quarter are 0.29 EUR per share, whereas the estimation was 0.23 EUR resulting in a +26.3% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Elanco Animal Health revenue for the last year?▼
Elanco Animal Health revenue for the last year amounts to 4.1B EUR.
What is Elanco Animal Health net income for the last year?▼
5EA.STU net income for the last year is -192.94M EUR.
How many employees does Elanco Animal Health have?▼
As of September 08, 2026, the company has 9,900 employees.
In which sector is Elanco Animal Health located?▼
Elanco Animal Health operates in the Health & Wellness sector.
When did Elanco Animal Health complete a stock split?▼
Elanco Animal Health has not had any recent stock splits.
Where is Elanco Animal Health headquartered?▼
Elanco Animal Health is headquartered in INDIANAPOLIS, United States.